lobbying_activities: 1733020

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1733020	1bc29771-b831-417f-a5de-a6b763413d93	3A	AMERICAN VETERINARY MEDICAL ASSOCIATION	3630	AMERICAN VETERINARY MEDICAL ASSOCIATION	2015	third_quarter	PHA	Guidance for Industry: Compounding Animal Drugs from Bulk Substances Discussions with Congressional staff, FDA and USDA regarding the use of antimicrobials in food-producing animals, particularly with respect to H.R.1552 (Preservation of Antibiotics for Medical Treatment Act), S. 621 (Preventing Antibiotic Resistance Act), and FDA's strategy (GRI #209 and VFD Rule) Discussions with Congressional staff, FDA and Government Accountability Office to express the need for compounding of medications for use in animals and FDA's draft GFI #230 Inquiries to, and discussions with, Congressional staff on veterinary pet prescriptions, particularly regarding H.R. 317/S. 1200, the Fairness to Pet Owners Act.	Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE		220000	0	0	2015-10-16T09:05:14.283000-04:00